INSUBCONTINENT EXCLUSIVE:
Shubham Aggarwal of Quantsapp Advisory has a sell call on Glenmark Pharmaceuticals Ltd
with a target price of Rs 304.0
The current price of Glenmark Pharmaceuticals Ltd
is Rs 318.65 Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd
price can reach defined target.Shubham Aggarwal recommended to keep a stoploss at Rs 330
Glenmark Pharmaceuticals Ltd., incorporated in 1977, has a market cap of Rs 8991.29 crore.
Glenmark Pharmaceuticals Ltd
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6042.06 Crore to Sales Value (93.93 % of Total Sales), Other
Operating Revenue which contributed Rs 335.83 Crore to Sales Value (5.22 % of Total Sales) and Sale of services which contributed Rs 54.00
Crore to Sales Value (0.83 % of Total Sales)for the year ending 31-Mar-2018
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 2763.73 Crore, up 21.02 % from last quarter Sales of
Rs 2283.60 Crore and up 8.81 % from last year same quarter Sales of Rs 2539.86 Crore Company has reported net profit after tax of Rs 255.54
Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto, Ms.Saira Ramasastry
Company has Walker, Chandiok - Co.LLP as its auditors As on 31-12-2019, the company has a total of 282,168,156 shares outstanding.